Table 2.
Novel sites of P-SSG with greatest fold change after stimulation. Table of novel P-SSG modifications significantly affected by fatiguing contractions and with a fold change greater than 1.68. Significance determined by p-value (≤ 0.05). Note: Some P-SSG sites were no longer significant with FDR correction.
Protein | Cysteine Site(s) | Log2 FC | P value | FDR |
---|---|---|---|---|
14-3-3 protein gamma | 112 | 1.023413 | 0.012581 | 0.029635 |
97 | 0.829382 | 0.013471 | 0.030999 | |
ARL14 effector protein-like | 100 | 1.386748 | 0.015173 | 0.032951 |
92 | 1.386748 | 0.015173 | 0.032951 | |
98 | 1.386748 | 0.015173 | 0.032951 | |
Activating signal cointegrator 1 complex subunit 3 | 2004 | 0.824314 | 0.032172 | 0.055351 |
Dual specificity mitogen-activated protein kinase kinase 4 | 264 | 0.854978 | 0.040535 | 0.066078 |
Myosin heavy chain 1 | 480 | 0.97775 | 0.048739 | 0.075581 |
Myosin heavy chain 2b | 523 | 0.942909 | 0.015117 | 0.032951 |
541 | 0.907055 | 0.01224 | 0.029316 | |
Myosin light chain 1/3, skeletal muscle isoform | 62 | 0.781071 | 0.009289 | 0.025048 |
NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | 223 | 1.24754 | 0.009351 | 0.025096 |
224 | 1.24754 | 0.009351 | 0.025096 | |
Phosphomannomutase 2 | 99 | 0.772268 | 0.005397 | 0.01863 |
Ribosome-binding protein 1 | 1415 | 0.786351 | 0.03373 | 0.05748 |
Sciellin | 606 | 1.08025 | 0.010851 | 0.027299 |
617 | 1.08343 | 0.01201 | 0.02895 | |
Histone-lysine N-methyltransferase Smyd1 | 332 | 0.775664 | 0.012484 | 0.029529 |
335 | 0.775664 | 0.012484 | 0.029529 | |
Sarcalumenin | 648 | 1.043884 | 0.018395 | 0.037535 |
Synaptophysin-like protein 2 | 155 | 0.775554 | 0.048596 | 0.075513 |